scholarly article | Q13442814 |
P2093 | author name string | Andreas H Wagner | |
Thomas Korff | |||
Carsten Sticht | |||
Markus Hecker | |||
Caroline Arnold | |||
Hanna Kuk | |||
P2860 | cites work | A matrix metalloproteinase expressed on the surface of invasive tumour cells | Q24312733 |
Revision of the CEAP classification for chronic venous disorders: consensus statement | Q28300287 | ||
Cytokine-inducible CD40 gene expression in vascular smooth muscle cells is mediated by nuclear factor kappaB and signal transducer and activation of transcription-1 | Q28570672 | ||
Endothelial cell spheroids as a versatile tool to study angiogenesis in vitro. | Q52952706 | ||
Experimental hypertension triggers varicosis-like maladaptive venous remodeling through activator protein-1. | Q53239684 | ||
Licorice inhibits corticosteroid 11 beta-dehydrogenase of rat kidney and liver: in vivo and in vitro studies | Q69665015 | ||
Cyclic strain causes heterogeneous induction of transcription factors, AP-1, CRE binding protein and NF-kB, in endothelial cells: species and vascular bed diversity | Q71151146 | ||
World Medical Association declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects | Q73135842 | ||
Morphologic characteristics of varicose veins: possible role of metalloproteinases | Q73618854 | ||
The development of collateral circulation in the mouse's ear | Q78375138 | ||
Matrix metalloproteinases in the vein wall | Q80914344 | ||
Inhibitory effects of triterpenes and flavonoids on the enzymatic activity of hyaluronic acid-splitting enzymes | Q83828057 | ||
Junctional and nonjunctional effects of heptanol and glycyrrhetinic acid derivates in rat mesenteric small arteries | Q35047408 | ||
Glycyrrhetinic acid induces G1‑phase cell cycle arrest in human non‑small cell lung cancer cells through endoplasmic reticulum stress pathway | Q35073336 | ||
18β-Glycyrrhetinic acid suppresses cell proliferation through inhibiting thromboxane synthase in non-small cell lung cancer | Q35138733 | ||
Varicose veins: role of mechanotransduction of venous hypertension. | Q35829875 | ||
Management of reticular veins and telangiectases | Q35837999 | ||
Effects of topical application of B-Resorcinol and Glycyrrhetinic acid monotherapy and in combination with fractional CO2 laser treatment for benign hand hyperpigmentation treatment. | Q36057364 | ||
Electrical conduction along endothelial cell tubes from mouse feed arteries: confounding actions of glycyrrhetinic acid derivatives | Q36159248 | ||
Glycyrrhetinic acid induces cytoprotective autophagy via the inositol-requiring enzyme 1α-c-Jun N-terminal kinase cascade in non-small cell lung cancer cells | Q36685537 | ||
Varicose Remodeling of Veins Is Suppressed by 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors | Q36714057 | ||
Involvement of gap junctions between smooth muscle cells in sustained hypoxic pulmonary vasoconstriction development: a potential role for 15-HETE and 20-HETE | Q36811256 | ||
Prolonged increases in vein wall tension increase matrix metalloproteinases and decrease constriction in rat vena cava: Potential implications in varicose veins | Q36953739 | ||
Mechanisms of varicose vein formation: valve dysfunction and wall dilation | Q37153376 | ||
Cyclic stretch induces cyclooxygenase-2 gene expression in vascular endothelial cells via activation of nuclear factor kappa-beta | Q37390752 | ||
Varicose veins and chronic venous insufficiency | Q37649602 | ||
Atopic dermatitis: an evidence-based treatment update. | Q38182048 | ||
Pathogenesis of varicose veins - lessons from biomechanics | Q38195809 | ||
Sclerotherapy of telangiectasias or spider veins in the lower limb: A review | Q38841092 | ||
18β-Glycyrrhetinic acid suppresses TNF-α induced matrix metalloproteinase-9 and vascular endothelial growth factor by suppressing the Akt-dependent NF-κB pathway | Q39016923 | ||
Glycyrrhetinic acid inhibits ICAM-1 expression via blocking JNK and NF-kappaB pathways in TNF-alpha-activated endothelial cells | Q39018324 | ||
Prevalence and risk factors of varicose veins in lower extremities: mini-Finland health survey. | Q39371466 | ||
Anatomy of the Superficial Venous System | Q40437896 | ||
The protective effect of 18β-Glycyrrhetinic acid against UV irradiation induced photoaging in mice | Q41700859 | ||
Lower extremity venous anatomy | Q41893599 | ||
Modulation by glycyrrhetinic acid derivatives of TPA-induced mouse ear oedema | Q42848271 | ||
Glycyrrhetinic acid attenuates vascular smooth muscle vasodilatory function in healthy humans. | Q43048882 | ||
Bortezomib protects from varicose-like venous remodeling | Q44580587 | ||
Synthesis of new glycyrrhetinic acid (GA) derivatives and their effects on tyrosinase activity | Q44671737 | ||
Glycyrrhetinic acid, the active principle of licorice, can reduce the thickness of subcutaneous thigh fat through topical application | Q46490629 | ||
Glycyrrhetinic acid prevents cutaneous scratching behavior in mice elicited by substance P or PAR-2 agonist | Q46528396 | ||
An animal model of venous hypertension: the role of inflammation in venous valve failure | Q46716828 | ||
HMG-CoA reductase inhibitors reduce matrix metalloproteinase-9 activity in human varicose veins | Q46933301 | ||
Magnolol inhibits venous remodeling in mice | Q47103261 | ||
Inhibition of mutagenicity in Salmonella typhimurium and skin tumor initiating and tumor promoting activities in SENCAR mice by glycyrrhetinic acid: comparison of 18 alpha- and 18 beta-stereoisomers. | Q50189733 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P4510 | describes a project that uses | ImageJ | Q1659584 |
P304 | page(s) | 320 | |
P577 | publication date | 2018-04-04 | |
P1433 | published in | Frontiers in Physiology | Q2434141 |
P1476 | title | Glycyrrhetinic Acid Antagonizes Pressure-Induced Venous Remodeling in Mice. | |
P478 | volume | 9 |